<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01479270</url>
  </required_header>
  <id_info>
    <org_study_id>IRB10-01517</org_study_id>
    <nct_id>NCT01479270</nct_id>
  </id_info>
  <brief_title>Transversus Abdominal Plane Block at Total Laparoscopic Hysterectomy: Effect on Quality of Recovery</brief_title>
  <acronym>TAP</acronym>
  <official_title>Randomized Trial of Transversus Abdominal Plane (TAP) Block at Total Laparoscopic Hysterectomy: Effect of Regional Analgesia on Quality of Recovery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MetroHealth Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MetroHealth Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Transversus Abdominal Plane (TAP) block has been used with good success to decrease
      postoperative pain following laparatomy. If the TAP block provides any improvement in the
      quality of recovery following laparoscopic hysterectomy, it could decrease the need for
      postoperative narcotics and allow for more outpatient hysterectomy procedures.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of Recovery Questionnaire (QoR-40) on Postop Day #1 or #2</measure>
    <time_frame>Postop Day #1 or Day #2</time_frame>
    <description>40 question survey completed on paper or by telephone on post-operative day #1 or #2, designed to measure health status after surgery and anesthesia. Scale ranges from 40 (extremely poor qualify of recovery) to 200 (excellent quality of recovery).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Narcotic Use</measure>
    <time_frame>Postop Day #0 and Day #1</time_frame>
    <description>narcotic use in mg of Morphine will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale (VAS) for Pain</measure>
    <time_frame>2 and 24 hours post operative</time_frame>
    <description>visual analogue scales for pain will be completed on post-operative day #0 and #1, pain is assessed on a 10-point visual analogue scale (0 = no pain; 1 to 3 = mild; 4 to 6 = moderate pain; 7 to 10 = severe pain.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative Time</measure>
    <time_frame>the total intraoperative time in minutes</time_frame>
    <description>The total time in the operating room will be recorded to see if there is a difference between groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>TAP Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20mL of 0.25% Ropivacaine with Epinephrine 1:200,000 is injected into bilateral transversus abdominal planes under ultrasound guidance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Block</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients randomized to this arm have band aids applied to sites on lateral abdomen without injection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TAP Block</intervention_name>
    <description>Bilateral transversus abdominal plane injection under ultrasound guidance, done at conclusion of hysterectomy procedure, prior to emergence from general anesthesia</description>
    <arm_group_label>TAP Block</arm_group_label>
    <other_name>Ropivacaine with Epinephrine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any patient undergoing laparoscopic hysterectomy

          -  Age ranges 18-80

          -  Reading literacy

          -  English speaking

          -  Able to give informed consent

        Exclusion Criteria:

          -  History of relevant drug allergy

          -  Chronic opioid users who may have tolerance to pain medications

          -  Inability to understand written consent forms or give consent

          -  Age less than 18 or over 80

          -  Any conversion to open surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah M Kane, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MetroHealth Medical Center</affiliation>
  </overall_official>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>November 22, 2011</study_first_submitted>
  <study_first_submitted_qc>November 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2011</study_first_posted>
  <results_first_submitted>May 10, 2018</results_first_submitted>
  <results_first_submitted_qc>October 5, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">October 11, 2018</results_first_posted>
  <last_update_submitted>October 5, 2018</last_update_submitted>
  <last_update_submitted_qc>October 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>MetroHealth Medical Center</investigator_affiliation>
    <investigator_full_name>Robert Pollard</investigator_full_name>
    <investigator_title>Clinical Fellow, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>recovery</keyword>
  <keyword>postoperative</keyword>
  <keyword>pain</keyword>
  <keyword>laparoscopy</keyword>
  <keyword>hysterectomy</keyword>
  <keyword>ropivacaine</keyword>
  <keyword>TAP block</keyword>
  <keyword>local anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Tap Block</title>
          <description>Patients undergoing Total Laparoscopic Hysterectomy were randomized with the Tap Block</description>
        </group>
        <group group_id="P2">
          <title>No Block</title>
          <description>Patients undergoing Total Laparoscopic Hysterectomy were randomized without Tap Block</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Tap Block</title>
          <description>Patients randomized to either Tap Block or No Tap Block</description>
        </group>
        <group group_id="B2">
          <title>No Block</title>
          <description>Patients randomized to either Tap Block or No Tap Block</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="28"/>
            <count group_id="B2" value="28"/>
            <count group_id="B3" value="56"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="56"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="56"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Quality of Recovery Questionnaire (QoR-40) on Postop Day #1 or #2</title>
        <description>40 question survey completed on paper or by telephone on post-operative day #1 or #2, designed to measure health status after surgery and anesthesia. Scale ranges from 40 (extremely poor qualify of recovery) to 200 (excellent quality of recovery).</description>
        <time_frame>Postop Day #1 or Day #2</time_frame>
        <group_list>
          <group group_id="O1">
            <title>TAP Block</title>
            <description>20mL of 0.25% Ropivacaine with Epinephrine 1:200,000 is injected into bilateral transversus abdominal planes under ultrasound guidance.
TAP Block of 0.25% Ropivacaine with 1:200,000 Epinephrine: Bilateral transversus abdominal plane injection under ultrasound guidance, done at conclusion of hysterectomy procedure, prior to emergence from general anesthesia</description>
          </group>
          <group group_id="O2">
            <title>No Block</title>
            <description>Patients randomized to this arm have band aids applied to sites on lateral abdomen without injection.</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Recovery Questionnaire (QoR-40) on Postop Day #1 or #2</title>
          <description>40 question survey completed on paper or by telephone on post-operative day #1 or #2, designed to measure health status after surgery and anesthesia. Scale ranges from 40 (extremely poor qualify of recovery) to 200 (excellent quality of recovery).</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="168.0" lower_limit="125" upper_limit="195"/>
                    <measurement group_id="O2" value="169.5" lower_limit="116" upper_limit="194"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Narcotic Use</title>
        <description>narcotic use in mg of Morphine will be recorded</description>
        <time_frame>Postop Day #0 and Day #1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tap Block</title>
            <description>Patients undergoing Total Laparoscopic Hysterectomy were randomized to either the Tap Block or Nothing</description>
          </group>
          <group group_id="O2">
            <title>No Block</title>
            <description>Patients undergoing Total Laparoscopic Hysterectomy were randomized to either the Tap Block or Nothing</description>
          </group>
        </group_list>
        <measure>
          <title>Narcotic Use</title>
          <description>narcotic use in mg of Morphine will be recorded</description>
          <units>mg of morphine</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Post operative day #0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.7" lower_limit="0" upper_limit="24"/>
                    <measurement group_id="O2" value="11.8" lower_limit="0" upper_limit="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post operative day #1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.5" lower_limit="3" upper_limit="25"/>
                    <measurement group_id="O2" value="9.0" lower_limit="3" upper_limit="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Analog Scale (VAS) for Pain</title>
        <description>visual analogue scales for pain will be completed on post-operative day #0 and #1, pain is assessed on a 10-point visual analogue scale (0 = no pain; 1 to 3 = mild; 4 to 6 = moderate pain; 7 to 10 = severe pain.)</description>
        <time_frame>2 and 24 hours post operative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tap Block</title>
            <description>Patients undergoing Total Laparoscopic Hysterectomy were randomized to either the Tap Block or Nothing</description>
          </group>
          <group group_id="O2">
            <title>No Block</title>
            <description>Patients undergoing Total Laparoscopic Hysterectomy were randomized to either the Tap Block or Nothing</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Scale (VAS) for Pain</title>
          <description>visual analogue scales for pain will be completed on post-operative day #0 and #1, pain is assessed on a 10-point visual analogue scale (0 = no pain; 1 to 3 = mild; 4 to 6 = moderate pain; 7 to 10 = severe pain.)</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>2 hours post operative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O2" value="6.0" lower_limit="2" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours post operative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" lower_limit="0" upper_limit="8"/>
                    <measurement group_id="O2" value="5.0" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intraoperative Time</title>
        <description>The total time in the operating room will be recorded to see if there is a difference between groups.</description>
        <time_frame>the total intraoperative time in minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>TAP Block</title>
            <description>Patients undergoing Total Laparoscopic Hysterectomy were randomized to either the Tap Block or Nothing</description>
          </group>
          <group group_id="O2">
            <title>No Block</title>
            <description>Patients undergoing Total Laparoscopic Hysterectomy were randomized to either the Tap Block or Nothing</description>
          </group>
        </group_list>
        <measure>
          <title>Intraoperative Time</title>
          <description>The total time in the operating room will be recorded to see if there is a difference between groups.</description>
          <units>Minutes</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.4" lower_limit="2.4" upper_limit="108.6"/>
                    <measurement group_id="O2" value="34.5" lower_limit="10.8" upper_limit="109.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>TAP Block</title>
          <description>Patients undergoing Total Laparoscopic Hysterectomy were randomized to either the Tap Block or Nothing</description>
        </group>
        <group group_id="E2">
          <title>No Block</title>
          <description>Patients undergoing Total Laparoscopic Hysterectomy were randomized to either the Tap Block or Nothing</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Robert Pollard</name_or_title>
      <organization>MetroHealth Medical Center</organization>
      <phone>216-778-4444</phone>
      <email>rpollard@metrohealth.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

